Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Res Vet Sci ; 92(3): 401-7, 2012 Jun.
Article in English | MEDLINE | ID: mdl-21489584

ABSTRACT

Twenty-four female BALB/c mice were orally inoculated with 10(8) CFU Escherichia coli ATCC 25922 and euthanized 2.5, 7, 13 and 25 h post-inoculation. The levels of organ nitric oxide (NO) and plasma endotoxin, TNF-alpha and nitrite/nitrate (NO(x)) were compared to those found in sham-inoculated mice, to evaluate systemic host-response to a low-level oral exposure to Gram-negative bacteria. Organ bacterial culture and immunohistochemistry for iNOS were performed on lungs, liver, kidneys and brain from all mice. Organ NO and plasma TNF-alpha levels were higher in E. coli-inoculated animals, but no differences were detected in plasma endotoxin levels, NO(x) or iNOS immunostaining for any of the animal groups. Single oral gavage with live E. coli stimulates an early systemic immune response in clinically healthy mice as evidenced by increased plasma TNF-alpha and organ NO levels, but bacteremia and endotoxemia are not related to this inflammatory response.


Subject(s)
Escherichia coli Infections/immunology , Nitric Oxide/metabolism , Systemic Inflammatory Response Syndrome/microbiology , Tumor Necrosis Factor-alpha/metabolism , Animals , Brain/enzymology , Brain/immunology , Female , Immunohistochemistry , Kidney/enzymology , Kidney/immunology , Liver/enzymology , Liver/immunology , Lung/enzymology , Lung/immunology , Mice , Mice, Inbred BALB C , Nitric Oxide/blood , Nitric Oxide Synthase Type II , Specific Pathogen-Free Organisms , Tumor Necrosis Factor-alpha/blood
2.
Arch Oral Biol ; 55(7): 509-14, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20430367

ABSTRACT

OBJECTIVE: Nitric oxide synthase (NOS) inhibitors are reported to protect against the local tissue damage in gingivitis and periodontal disease by reducing nitroxidative stress during inflammation, but their systemic effects are not well investigated. DESIGN: NOS inhibitors systemic effects were investigated in a murine chronic oral inoculation model using live Porphyromonas gingivalis ATCC 33277 (0.3 ml; 10(9)cfu/ml) or sterile broth (0.3 ml). Organ nitric oxide (NO) and plasma nitrite/nitrate (NOx) were determined in mice treated with non-selective NOS inhibitor l-NAME (50mg/kg/24h i.p.) or selective iNOS inhibitor 1400W (10mg/kg/6h i.p.) for the last 5 days of the experiment. Differences between groups were evaluated by nonparametric Wilcoxon's rank-sum one-sided two-sample test and the results compared to those obtained from sham-treated (sterile broth) sham-inoculated animals (water for injection i.p./6h). RESULTS: Repeated ingestion of P. gingivalis resulted in generalized production of NO in organs and NOx in plasma, the levels of both typically being reduced in P. gingivalis-inoculated-1400W-treated mice, whilst the use of l-NAME was largerly ineffective, even promoting NO/NOx formation. Application of either inhibitor to sham-inoculated animals enhanced NO/NOx formation, due only in part to the repeated i.p. injections. CONCLUSIONS: The systemic use of 1400W or l-NAME differently affects systemic nitric oxide formation in mice orally challenged with P. gingivalis, but the sequelae of such an intervention should be evaluated further.


Subject(s)
Amidines/pharmacology , Benzylamines/pharmacology , Enzyme Inhibitors/pharmacology , Free Radical Scavengers/metabolism , Mouth/microbiology , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide Synthase Type II/antagonists & inhibitors , Nitric Oxide/metabolism , Porphyromonas gingivalis/physiology , Animals , Aorta, Thoracic/metabolism , Female , Kidney/metabolism , Liver/metabolism , Lung/metabolism , Mice , Mice, Inbred BALB C , Models, Animal , Mouth Mucosa/microbiology , Myocardium/metabolism , Nitrates/blood , Nitrites/blood , Random Allocation , Spleen/metabolism , Tissue Distribution
SELECTION OF CITATIONS
SEARCH DETAIL
...